QI
RPRX icon

Qtron Investments’s Royalty Pharma RPRX Stock Holding History

Qtron Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$887K Buy
18,481
+2,063
+13% +$90.4K 0.12% 212
2025
Q4 		$634K Buy
16,418
+2,178
+15% +$83.1K 0.08% 270
2025
Q3 		$502K Buy
14,240
+2,938
+26% +$106K 0.06% 327
2025
Q2 		$407K Buy
+11,302
New +$374K 0.05% 362
2023
Q1 		– Sell
-9,895
Closed -$391K – 450
2022
Q4 		$391K Hold
9,895
– – 0.08% 301
2022
Q3 		$398K Buy
+9,895
New +$423K 0.1% 276

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Qtron Investments's RPRX Position: Q1 2026 in Review

Qtron Investments increased its Royalty Pharma (RPRX) stake by 13% in Q1 2026, buying an estimated $90.4K and bringing the position to 18,481 shares worth $887K. The position accounts for 0.12% of the portfolio, ranked #212.

Qtron Investments first reported a position in RPRX in Q3 2022 and has held it in 6 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Qtron Investments held 18,481 shares of Royalty Pharma worth $887K as of Q1 2026.
  • Qtron Investments bought 2,063 Royalty Pharma shares in Q1 2026, an estimated $90.4K.
  • Royalty Pharma made up 0.12% of Qtron Investments's portfolio in Q1 2026, its #212 holding.
  • Qtron Investments first reported a position in Royalty Pharma in Q3 2022 and has held it in 6 quarters since.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Qtron Investments's 13F filing for Q1 2026, filed 15 May 2026.